Search results for " Sang"

showing 10 items of 268 documents

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis

2009

Abstract Abstract 3999 Poster Board III-935 Background Clinical advantage of extensive screening for occult cancer in patients with idiopathic Deep Vein Thrombosis (DVT) is unknown. We have demonstrated that the Residual Vein Thrombosis (RVT)-based screening for occult cancer improves early detection as well as cancer-related mortality (Siragusa S et al. Blood 2007;110(699):OC). Here we report on final analysis of 537 patients over a period of 8 years. Objective of the study We conducted a prospective study evaluating whether a RVT-based screening for cancer is sensitive and influences cancer-related mortality. Study design Prospective with two cohorts of DVT patients: the first cohort was …

First episodemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryDeep veinImmunologyCancerColonoscopyCell BiologyHematologymedicine.diseaseBiochemistryOccultSurgerycancer residual vein thrombosisSettore MED/15 - Malattie Del Sanguemedicine.anatomical_structureInternal medicineCohortCancer screeningmedicineProspective cohort studybusiness
researchProduct

Le cube des fluides. Du poil au sang en Sicile

2010

Fluides Sicile Sang poils Cube des Fluides
researchProduct

Knowledge gaps and future directions in cognitive functions in children and adolescents with primary arterial hypertension: A systematic review

2022

Arterial hypertension (AH) among adults is known to be associated with worse cognitive outcomes. Similarly, children and adolescents with AH could be expected to underperform during neuropsychological evaluations when compared with healthy peers. Our aims were to review the existing literature on cognitive functioning among children and adolescents with primary AH and to identify what additional evidence may be needed to substantiate the impact of hypertension on poor cognitive outcomes in this population. We conducted a systematic review of articles in PubMed and Web of Science published before 17 January 2022, reporting on cognitive testing among children and adolescents with primary AH. …

Funcions executives (Neuropsicologia)JovesPressió sanguíniaNeuropsicologia pediàtricaChildhoodAdolescènciaAdolescencePediatric neuropsychologyBlood pressureblood pressure ; primary arterial hypertension ; executive functions ; neuropsychology ; pediatrics ; childhood ; adolescence ; HyperChildNETExecutive functions (Neuropsychology)Cardiology and Cardiovascular MedicineInfantsInfància
researchProduct

Pre-Emptive Treatment with Cidofovir for Cytomegalovirus Antigenemia in Autologous Bone Marrow Recipient and CLL Patients on Therapy with Alemtuzumab.

2006

Abstract Cytomegalovirus (CMV) is an important cause of morbidity and mortality in patients who have undergone severe immunosuppressive therapy. Ganciclovir continues to be the first choice for pre-emptive therapy, but it needs multiple intravenous daily administration for three weeks and may cause myelosuppression. Cidofovir is a non myelotoxic nucleotide analogue effective against CMV; its favourable pharmacokinetic profile allows a once-a-week dosing. We reviewed a database on 110 consecutive Autologous Stem Cell Transplant (ASCT) and that of 15 Chronic Lymphocytic Leukemia (CLL) patients treated with alemtuzumab. All patients were virologically monitored by quantification of pp65 antige…

Ganciclovirmedicine.medical_specialtyNauseaChronic lymphocytic leukemiaImmunologyCongenital cytomegalovirus infectionBiochemistryGastroenterologySettore MED/15 - Malattie Del Sanguechemistry.chemical_compoundInternal medicinemedicineProteinuriabusiness.industryvirus diseasesCell BiologyHematologymedicine.diseaseSurgerychemistryVomitingCytomegalovirus pre-emptive treatment cidofovirAlemtuzumabmedicine.symptombusinessmedicine.drugCidofovirBlood
researchProduct

A short screener is valid for assessing mediterranean diet adherence among older spanish men and women

2011

6 páginas.

GerontologyBlood GlucoseMaleQuestionnairesMediterranean dietIntraclass correlationLípids de la sangMedicine (miscellaneous)Coronary Artery DiseaseDiet MediterraneanDieta mediterràniaCoronary artery diseasePersones granslaw.inventionCoronary diseasesRandomized controlled triallawRisk FactorsSurveys and QuestionnairesSucre en l'organismeolder men and womenMedicineadherenceAged 80 and overBioquímica y tecnologíaNutrition and DieteticsFactors de risc en les malaltiesMiddle AgedLipidsBiochemistry and technologyWaist circumferenceFemaleWaist CircumferenceWaistRisk factors in diseasesSugar in the bodyQüestionarisPacients -- CooperacióBioquímica i biotecnologiaMalalties coronàriesDiet SurveysMedicina preventivaMediterranean cookingMediterranean dietLinear regressionCuina mediterràniaBlood glucoseHumansBland–Altman plotEspanyaAgedPreventive medicinebusiness.industryConstruct validityDiet SurveysDietRisk factorsSpainLinear ModelsBlood lipidsPatient CompliancePreventive MedicineOlder peoplebusiness0022-3166Demography
researchProduct

About the Ambassador Vich Palace s distribution and some thoughts on its patio

2019

[ES] El palacio del Embajador Vich es todavía una de las grandes asignaturas pendientes de la historiografía valenciana. Su patio, reconstruido en el Museo de Bellas Artes de Valencia, ha sido estudiado por diversos autores en las últimas décadas y se ha relacionado con el panorama romano de la época, asumiendo no obstante su autoría local. En cuanto al resto del edificio, apenas se ha tratado sobre él, más allá de algunas interpretaciones basadas en los planos de Tosca y Fortea. En el presente artículo pretendemos contribuir a conocer algo mejor la residencia histórica de los barones de Llaurí a partir de dos inventarios del siglo XVII. Igualmente reflexionaremos sobre algunas incógnitas t…

Giuliano da SangalloArquitectura del RenacimientoUNESCO::HISTORIAVisual Arts and Performing ArtsSerlianaEmbajador VichValencia:HISTORIA [UNESCO]COMPOSICION ARQUITECTONICARenaissance architectureAmbassador VichFernando Yáñez de la Almedina
researchProduct

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled tr…

2018

Introduction Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. Methods and analysis MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hyp…

HYPERTENSION MANAGEMENTHipertensión.1302masked uncontrolled hypertensionEnfermedades cardiovasculares - Pacientes - Factores de riesgo.office blood pressureMASKED UNCONTROLLED HYPERTENSIONMedicina ClínicaCardiovascular Medicine030204 cardiovascular system & hematologyAMBULATORY BLOOD PRESSURE MONITORINGlaw.invention0302 clinical medicineClinical trialsRandomized controlled triallawBlood Pressure MonitoringMasked Hypertension//purl.org/becyt/ford/3.2 [https]ProtocolMulticenter Studies as Topic1506030212 general & internal medicineCardiovascular system - Diseases - Patients - Risk factors.Blood pressure.OFFICE BLOOD PRESSURERandomized Controlled Trials as TopicSistemas Cardíaco y CardiovascularGeneral MedicineBlood Pressure Monitoring Ambulatory3. Good healthCor MalaltiesEchocardiographyAmbulatoryHypertensionBlood pressure//purl.org/becyt/ford/3 [https]Hipertensióambulatory blood pressure monitoring; hypertension; hypertension management; masked uncontrolled hypertension; office blood pressure; treated hypertensive patientsTREATED HYPERTENSIVE PATIENTS1683medicine.medical_specialtyAmbulatory blood pressureCIENCIAS MÉDICAS Y DE LA SALUDhypertensionHeart Ventriclestreated hypertensive patientPressió sanguínia03 medical and health sciencesAmbulatoryHypertension.medicineAlbuminuriaHumansAntihypertensive AgentsProtocol (science)business.industryConsolidated Standards of Reporting Trialsambulatory blood pressure monitoring; hypertension; hypertension management; masked uncontrolled hypertension; office blood pressure; treated hypertensive patients; Albuminuria; Antihypertensive Agents; Echocardiography; Heart Ventricles; Humans; Masked Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Blood Pressure Monitoring Ambulatorytreated hypertensive patientsambulatory blood pressure monitoringBlood pressurePresión sanguínea.Good clinical practiceEmergency medicinebusinessDeclaration of Helsinkihypertension managementAssaigs clínicsBMJ Open
researchProduct

Ileus following spontaneous jejunum intramural hematoma: case report and review of the literature.

2013

Anticoagulant therapy may cause the onset of a spontaneous intramural hema- toma of the small bowel, in the jejunum, ileum or duodenum. A 53-year-old woman on therapy with heparin for previous pulmonary embolism was admitted for abdominal pain and vomit. Computed tomography scan visualized an intramural hematoma of the jejunum causing subtotal obstruction of the intestinal lumen. The patient underwent resection of a part of the jejunum, securing intestinal continuity by a mechanical side-to-side anastomosis. The postoperative course was regular, but the initial anticoagulant therapy was reduced to prevent recurrence. In conclusion, spontaneous hema- toma of small bowel can occur as a compli…

HematomaHeparinSpontaneous intramural hematomaAnticoagulantsJejunal DiseasesMiddle AgedSettore MED/15 - Malattie Del SangueSettore MED/18 - Chirurgia GeneraleIleusHumansFemaleSpontaneous intramural hematoma; Anticoagulant therapy; Bowel obstructionAnticoagulant therapyBowel obstruction
researchProduct

SUCCESFULLY TREATED HEMOLITIC UREMIC SYNDROME (HUS) BY PLASMA APHERESIS AFTER KIDNEY TRANSPLANTATION

2009

Objectives: The HUS is a rare disease; it exists a kind related to acute toxicity by Cyclosporine on the short time following kidney transplantation. Although the causes of this syndrome are still unclear, data from the literature show that patients with high levels of Reactive Antibodies (PRA test), Alport syndrome (as primitive renal disease), or which have history of HUS present a higher risk of HUS after renal transplantation. Materials and Methods: We report a case of a 58 yr old woman whose cause of uremia we did not know dependent on an episode of HUS. The patients underwent renal transplantation from deceased donor and treated with Cyclosporine, Mycophenolate Mofetil and steroids as…

Hemolitic uremic syndrome Kidney transplantationSettore MED/18 - Chirurgia GeneraleSettore MED/15 - Malattie Del Sangue
researchProduct

Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating…

2015

BACKGROUND: Despite the good safety of rivaroxaban, there is limited information on strategies for urgent reversal of its antihemostatic effects.Methods and Results:Alterations of hemostasis induced by rivaroxaban (230 ng/ml) were assessed by using several tests applied to steady and circulating human blood. Effects on thrombin generation (TG) and thromboelastometry (TEM) parameters were measured. Modifications in platelet adhesive, aggregating and procoagulant activities were evaluated in studies with circulating blood. The potential reversal of prothrombin complex concentrates (PCCs; 50 IU/kg), activated PCCs (aPCCs; 75 IU/kg), or recombinant factor VIIa (rFVIIa; 270 μg/kg) was evaluated.…

HemostàsiaPharmacologyFibrinAssaigs clínics de medicamentsRivaroxabanMedicineHumansPlateletFactor VIIIaCoagulació sanguíniaRivaroxabanHemostasisFactor VIIIbiologybusiness.industryDrugsDrug testingGeneral MedicineBlood coagulationBlood Coagulation FactorsThromboelastometryCoagulationRecombinant factor VIIaHemostasisAnesthesiabiology.proteinCardiology and Cardiovascular MedicinebusinessPerfusionMedicamentsmedicine.drugCirculation journal : official journal of the Japanese Circulation Society
researchProduct